Thymidine phosphorylase/platelet-derived endothelial cell growth factor expression associated with hepatic metastasis in gastric carcinoma

British Journal of Cancer

Volumn 73, Issue 8, 1996, Pages 884-888

  Maeda, K ^a   Chung, Y S ^a   Ogawa, Y ^a   Takatsuka, S ^a   Kang, S M ^a   Ogawa, M ^a   Sawada, T ^a   Onoda, N ^a   Kato, Y ^a   Sowa, M ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Angiogenesis; Gastric carcinoma; Hepatic metastasis; Platelet derived endothelial cell growth factor; Thymidine phosphorylase

Indexed keywords

PLATELET DERIVED ENDOTHELIAL CELL GROWTH FACTOR; THYMIDINE PHOSPHORYLASE; VON WILLEBRAND FACTOR;

ANGIOGENESIS; ARTICLE; ENDOTHELIUM CELL; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER METASTASIS; MICROVASCULATURE; PRIORITY JOURNAL; STOMACH CARCINOMA;

EID: 0029997353     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1996.177     Document Type: Article

References (21)

1. BOSARI S, LEE AKC, DELELLIS RA, WILEY BD, HEATLEY GJ AND SILVERMAN ML. (1992). Microvessel quantitation and prognosis in invasive breast carcinoma. Hum. Pathol., 23, 755-761.
2. COX DR. (1972). Regression models and life tables. J.R. Stat. Soc. B., 34, 187-220.
3. FOLKMAN J. (1990). What is the evidence that tumours are angiogenesis dependent? J. Natl Cancer Inst., 82, 4-6.
4. FOLKMAN J. (1992). The role of angiogenesis in tumour growth. Semin. Cancer Biol., 3, 65-71.
5. FUJII Y, ITOYANAGI H, SAEGUSA Y, HASUMI K AND ERIGUCHI M. (1994). Effects of 5′-DFUR against BALB/c retroperitoneal sarcoma with spontaneous liver metastases. Jpn. J. Cancer Chemother., 21, 1627-1631.
6. FURUKAWA T, YOSHIMURA A, SUMIZAWA T, HARAGUCHI M, AKIYAMA S, FUKUI K, ISHIZAWA M AND YAMADA Y. (1992). Angiogenic factor. Nature, 356, 668.
7. GASPARINI G, WEIDNER N, BEVILACQUA P, MALUTA S, PALMA PD, CAFFO O, BARBARESCHI M, BORACCHI P, MARUBINI E AND POZZA F. (1994). Tumour microvessel density, p53 expression, tumour size, and peritumoural lymphatic vessel invasion are relevant prognostic marker in node-negative breast carcinoma. J. Clin. Oncol., 12, 454-466.
8. HARAGUCHI M, MIYADERA K, UEMURA K, SUMIZAWA T, FURUKAWA T, YAMADA K, AKIYAMA S AND YAMADA Y. (1994). Angiogenic activity of enzymes. Nature, 368, 198.
9. ISHIKAWA F, MIYAZONO K, HELLMAN U, DREXLER H, WERNSTEDT C, HAGIWARA K, USUKI K, TAKAKU F, RISAU W AND HELDIN CH. (1989). Identification of angiogenic activity and the cloning and expression of platelet-derived endothelial cell growth factor. Nature, 338, 557-562.
10. ISHITSUKA H, MIWA M, TAKEMOTO K, FUKUOKA K, ITOGA A AND MARUYAMA HB. (1980). Role of uridine phosphorylase for antitumor activity of 5′-deoxy-5-fluorouridine. Gann., 71, 112-123.
11. JAPANESE RESEARCH SOCIETY FOR GASTRIC CANCER (1981). The general rules for gastric cancer study. Jpn. J. Surg., 11, 127-139.
12. LIOTTA LA, KLEINERMAN J AND SAIDEL G. (1976). The significance of hematogenous tumour cell clumps in the metastatic process. Cancer Res., 36, 889-894.
13. MAEDA K, CHUNG YS, TAKATSUKA S, OGAWA Y, SAWADA T, YAMASHITA Y, ONODA N, KATO Y, NITTA A, ARIMOTO Y, KONDO Y AND SOWA M. (1995). Tumor angiogenesis as a predictor of recurrence in gastric carcinoma. J. Clin. Oncol., 13, 477-481.
14. MIWA M, NISHIMURA J, KAMIYAMA T AND ISHITSUKA H. (1987). Conversion of 5′-deoxyfluorouridine to 5-FU by pyrimidine nucleoside phosphorylases in normal and tumor tissues from rodents bearing tumors and cancer patients. Jpn. J. Cancer Chemother., 14, 2924-2929.
15. NAGY JA, BROWN LF, SENGER DR, LANIR N, VAN DE WATER L, DVORAK AM AND DVORAK HF. (1989). Pathogenesis of tumour stroma generation: a critical role for leaky blood vessels and fibrin deposition. Biochem. Biophys. Acta., 948, 305-326.
16. NISHIDA M, HINO A, MORI K, MATSUMOTO T, TANAKA Y AND ISHITSUKA H. (1994). Cloning of hybridomas producing anti-human thymidine phosphorylase (dThdPase) and establishment ELISA for measuring dThdPase. J. Jpn. Soc. Cancer Ther., 29, 1192.
17. TOI M, HOSHINA S, TAKAYANAGI T AND TOMINAGA T. (1994). Association of vascular endothelial growth factor expression with tumor angiogenesis and with early relapse in primary breast carcinoma. Jpn. J.Cancer Res., 85, 1045-1049.
18. TOI M, HOSHINA S, TANIGUCHI T, YAMAMOTO Y, ISHITSUKA H AND TOMINAGA T. (1995). Expression of platelet-derived endothelial cell growth factor/thymidine phosphorylase in human breast cancer. Int. J. Cancer. (Pred. Oncol.), 64, 79-82.
19. USUKI K, SARAS J, WALTENBERGER J, MIYAZONO K, PIERCE G, THOMASON A AND HELDEN CH. (1992). Platelet-derived endothelial cell growth factor has thymidine phosphorylase activity. Biochem. Biophys. Res. Commun., 184, 1311-1316.
20. WEIDNER N, FOLKMAN J, POZZA F, BEVILACQUA P, ALLRED EN, MOORE DH, MELI S AND GASPARINI G. (1992). Tumour angiogenesis: a new significant and independent prognostic indicator in early-stage breast carcinoma. J. Natl Cancer Inst., 84, 1875-1887.
21. ZAGZAG D, MILLER DC, SATO Y, RIFKIN DB AND BURSTEIN DE. (1990). Immunohistochemical localization of basic fibroblast growth factor in astrocytomas. Cancer Res., 50, 7393-7398.